Atai Life Sciences N.V.

NASDAQ:ATAI

1.33 (USD) • At close December 31, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 29.96319.33323.86745.03476.492141.09185.885190.613142.53984.132123.975362.266430.308453.622104.36997.246-30.062
Short Term Investments 1569.01387.379109.223132.50286.40263.99882.496161.518228.354210.9390000060.124
Cash and Short Term Investments 44.963103.346111.246154.257208.994227.492249.883273.109304.057312.486334.914362.266430.308453.622104.36997.24630.062
Net Receivables 5.712.0762.4652.2570005.6315.3525.97.0976.3193.3861.34424.48600
Inventory 0000000-5.6316.7063.95.38611.1477.7042.5092.1990.4570
Other Current Assets 63.4112.4863.78929.0786.83115.27818.058.4058.0735.2226.7756.4978.1652.622.2642.3020
Total Current Assets 114.074117.908117.5185.592217.344242.77267.933287.145317.482323.608348.786375.082441.859457.586131.11999.54830.062
Non-Current Assets:
Property, Plant & Equipment, Net 1.8971.9162.0352.2042.252.412.6030.9280.7280.3030.1780.1490.1380.3310.140.0710
Goodwill 00000000000000000
Intangible Assets 00000000000000000
Goodwill and Intangible Assets 00000000000000000
Long Term Investments 45.22793.522147.012102.96275.173.9915.8466.7558.49810.39520.33627.75936.15842.7737.1128.0440
Tax Assets 00000000000000000
Other Non-Current Assets 36.3212.4322.5742.7213.4564.4244.33510.61315.88914.6314.43211.1765.9545.2716.893.885-30.062
Total Non-Current Assets 83.44597.87151.621107.88690.87610.82512.78418.29625.11525.32834.94639.08442.2548.37514.14212-30.062
Total Assets 197.519215.778269.121293.478308.22253.595280.717305.441342.597348.936383.732414.166484.109505.961145.261111.5480
Liabilities & Equity:
Current Liabilities:
Account Payables 4.883.8143.8434.5895.5063.8594.9152.3993.5112.7383.6126.0041.9746.2027.0313.0830
Short Term Debt 2.6630.4780.2440.550.5840.6440.6340.1800000.0380.0391.26500
Tax Payables 0.1820.3460.6950.7150.8870.8081.8822.2246.6776.887.7818.1375.9271.3232.4990.9970
Deferred Revenue 00-4.0870.71513.00812.8550000000.180.120.1200
Other Current Liabilities 11.91813.00610.23114.26612.71812.61512.52215.09415.72512.33910.6986.7947.1986.5018.1488.2180
Total Current Liabilities 19.64317.64415.01320.1219.69517.92620.87119.89725.91321.95722.09120.93515.31714.18519.06312.2980
Non-Current Liabilities:
Long Term Debt 21.14419.39316.20617.02716.37716.38316.3915.16115.0010.6190.7250.7430.81.1761.72.1770
Deferred Revenue Non-Current 00000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000
Other Non-Current Liabilities 10.41610.20814.64512.0153.6363.6493.7344.6175.6036.2386.5596.5295.2325.7054.5051.7050
Total Non-Current Liabilities 31.5629.60130.85129.04220.01320.032256.031280.51820.6046.8577.284384.186.0326.8816.2053.8820
Total Liabilities 51.20347.24545.86449.16239.70837.958276.902300.41546.51728.81429.375405.11521.34921.06625.26816.180
Equity:
Preferred Stock 00000000000000000
Common Stock 18.7718.76518.618.57318.57118.57118.57118.56218.55418.11418.00718.00217.8717.29915.25313.3720
Retained Earnings -661.249-634.963-577.651-550.938-532.647-576.891-543.849-510.188-465.178-431.29-394.672-357.803-268.926-237.768-189.307-189.9950
Accumulated Other Comprehensive Income/Loss -20.156-19.171-18.925-19.46-19.109-20.818-20.823-21.702-25.788-21.191-12.709-8.336-5.2333.9371.9775.81958.751
Other Total Stockholders Equity 808.355803.259800.52794.787799.461791.688782.926774.092761.811746.042735.38725.045709.475691.382424.335261.6261.029
Total Shareholders Equity 145.72167.89222.544242.962266.276212.55-546.101260.74289.399311.675346.006376.908453.186474.85111.3990.82259.78
Total Equity 146.316168.533223.257244.316268.512215.637-542.286265.766296.08320.122354.357385.959462.76484.895119.99395.36859.78
Total Liabilities & Shareholders Equity 197.519215.778269.121293.478308.22253.595280.717305.441342.597348.936383.732414.166484.109505.961145.261111.54859.78